000 | 01812 a2200505 4500 | ||
---|---|---|---|
005 | 20250515065337.0 | ||
264 | 0 | _c20070619 | |
008 | 200706s 0 0 eng d | ||
022 | _a0161-5505 | ||
024 | 7 |
_a10.2967/jnumed.106.036350 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAnjos, Dalton A | |
245 | 0 | 0 |
_a18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. _h[electronic resource] |
260 |
_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cMay 2007 |
||
300 |
_a764-70 p. _bdigital |
||
500 | _aPublication Type: Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFluorodeoxyglucose F18 |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImage Enhancement _xmethods |
650 | 0 | 4 |
_aImage Interpretation, Computer-Assisted _xmethods |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Invasiveness |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRadiopharmaceuticals |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aSubtraction Technique |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTomography, X-Ray Computed _xmethods |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdiagnosis |
700 | 1 | _aEtchebehere, Elba C S C | |
700 | 1 | _aRamos, Celso D | |
700 | 1 | _aSantos, Allan O | |
700 | 1 | _aAlbertotti, César | |
700 | 1 | _aCamargo, Edwaldo E | |
773 | 0 |
_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 48 _gno. 5 _gp. 764-70 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2967/jnumed.106.036350 _zAvailable from publisher's website |
999 |
_c17023664 _d17023664 |